GLP-1 medication a novel treatment for binge eating disorders

GLP-1 medication a novel treatment for binge eating disorders

New systematic review reveals GLP-1 medication as a novel treatment for binge eating disorders: Insights from Calle Mauritzson, Licensed Psychologist at Yazen.

A new study, published in the Journal of Clinical & Translational Endocrinology, has shown that treatment with GLP-1 medication is a promising novel approach for binge eating disorder and bulimia nervosa. Calle Mauritzson,  licensed psychologist at the healthcare provider Yazen, provides his perspective on why the integration of GLP-1 medication in the treatment of these conditions seems so effective.

1.  New understanding of binge eating and medical mechanisms: It’s crucial for care givers to understand how GLP-1 receptor agonists work. These medications can significantly reduce binge eating episodes by influencing the brain's appetite-regulating pathways, which helps in managing the disorder more effectively.

2. Regular meals with the aid of medicine: Combining regular meal patterns with the use of GLP-1 receptor agonists is essential. This approach helps stabilise appetite and prevent binge eating episodes, creating a structured eating routine that supports recovery.

3. Identify triggers and use medication as support: Using GLP-1 receptor agonists can reduce the physical urge to binge eat. Simultaneously, it's important for patients to work on identifying and managing their personal triggers and creating a comprehensive treatment plan.

4. Cognitive change and medication: Cognitive treatment becomes more effective when combined with medical treatment. GLP-1 receptor agonists can lessen the physical cravings, making it easier for patients to implement cognitive strategies and change negative thought patterns.

5. Alternative coping strategies and weight loss: Developing healthy coping strategies is vital. With the help of GLP-1 receptor agonists, patients can manage weight loss and improve their relationship with food, facilitating a healthier lifestyle

6. Physical activity with medical monitoring: Incorporating regular physical activity is an important part of the treatment plan. We need to consider the effects of GLP-1 receptor agonists on appetite and energy levels to tailor the physical activity to each patient’s needs."

7. Support network and medical treatment: A strong support network is invaluable. Emotional support from friends, family, or support groups, combined with the physiological benefits of GLP-1 receptor agonists, can greatly enhance the treatment process.

This comprehensive approach, integrating both medical treatment and behavioural strategies, provides a more effective and holistic treatment for patients struggling with binge eating disorder and bulimia nervosa.

‍

Read the interesting review: 

https://www.sciencedirect.com/science/article/pii/S2214623724000048

‍